Insider Trading25 Jun 2026, 06:31 pm
Zydus Lifesciences Closes Trading Window for Q1 FY27 Results
AI Summary
Zydus Lifesciences Limited has announced the closure of its trading window for Directors and Designated Persons, along with their immediate relatives. The window will be shut from Wednesday, July 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2026. This measure is in accordance with the company's Code of Insider Trading to prevent potential misuse of unpublished price-sensitive information. The date for the Board meeting to approve these financial results will be communicated separately.
Key Highlights
- Trading window closure for Q1 FY27 results announced.
- Effective from July 1, 2026, until 48 hours post-results.
- Applies to Directors, Designated Persons, and immediate relatives.
- Standard procedure under the Code of Insider Trading.
- Board meeting date for results approval to be announced later.
Price Impact
More from ZYDUSLIFE